Therapy with Zoledronic acid, 5 mg, for a patient with Paget's disease
Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global Paget's disease
market in future.
Consultant to Novartis on clinical aspects of Paget's disease
of bone: clinical, pathogenetic and therapeutic aspects.
GlobalData, the industry analysis specialist, has released its new report, Paget's Disease
of Bone (PDB) Therapeutics - Pipeline Assessment and Market Forecasts to 2018.
1 Drivers for the Paget's Disease
of Bone Therapeutics Market 33
Long-term outcome of patients with perianal Paget's disease
It is hoped the finding could lead to a screening test for Paget's disease
, which affects up to one million people in the UK, Nature Genetics reported.
The products--primarily approved to treat osteoporosis, slow bone turnover in Paget's disease
, and bone metastases in cancer patients--are alendronate (Fosamax, Fosamax Plus D), risedronate (Actonel, Actonel with Calcium), ibandronate (Boniva), zoledronic acid (Reclast, Zometa), pamidronate (Aredia), and etidronate.
is characterized by progressive bony deformity, with disorganized and excessive bone resorption and proliferation resulting in trabecular coarsening, cortical thickening, and generalized osseous enlargement.
of the nipple is a very rare form of breast cancer that can be fatal if left untreated.
In this paper, we focus on the role of measles virus in otosclerosis, and we review the current literature, devoting particular attention to a suspected paramyxoviral etiopathogenesis in Paget's disease